Bottom line
DEZRX vs BAGIX: the short answer
DEZRX (Nomura Extended Duration Bond Fund) and BAGIX (Baird Aggregate Bond Fund) are both mutual funds.
But BAGIX is far broader, holding 2,061 positions to 183 for DEZRX, so beyond the top names it adds exposure DEZRX doesn't have.
BAGIX is cheaper at 0.3% vs 0.48% — a difference of $18 a year per $10,000 invested.
Over five years, BAGIX returned −0.1% a year vs −1.9% for DEZRX (reporting dates differ).
Updated Nov 19, 2026
DEZRX vs BAGIX side by side
| DEZRX | BAGIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Voya | Baird |
| Category | Core / Intermediate Bond | Core / Intermediate Bond |
| Expense ratio | 0.48% | 0.3% |
| Annual cost per $10k | $48 | $30 |
| 10-yr cost on $10k (prospectus) | $805 | $381 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −1.3% | +7.4% |
| 5-yr return (annualized) | −1.9% | −0.1% |
| 10-yr return (annualized) | +1.8% | +2.4% |
| Best quarter | — | +7.2% |
| Worst quarter | — | −6.3% |
| Net assets (fund) | $242.1M | $57.9B |
| Number of holdings | 183 | 2,061 |
| Portfolio turnover | 119% | 34% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
DEZRX and BAGIX share none of their top holdings.
DEZRX top 10
- T-mobile USA Inc — 1.77%
- At&t Inc — 1.61%
- Amgen Inc — 1.60%
- Boeing Company (the) — 1.60%
- Union Pacific Corp — 1.59%
- Wells Fargo & Company — 1.50%
- Jp Morgan Chase & Company — 1.30%
- Lockheed Martin Corp — 1.29%
- Thermo Fisher Scientific Inc — 1.28%
- Elevance Health Inc — 1.24%
BAGIX top 10
- US Treasury N/b — 2.30%
- First American Government Obli — 2.13%
- US Treasury N/b — 1.99%
- US Treasury N/b — 1.46%
- US Treasury N/b — 1.40%
- US Treasury N/b — 1.34%
- US Treasury N/b — 1.27%
- US Treasury N/b — 1.19%
- US Treasury N/b — 1.17%
- US Treasury N/b — 1.13%
FAQ
What is the difference between DEZRX and BAGIX?
Which is cheaper, DEZRX or BAGIX?
Should I own both DEZRX and BAGIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.